ARCHIVES

DCT Moves Fast to Take Control Of Cooperative Groups, Get Multimodality Studies Under Way

This article is from The Cancer Letter archive.

Vol. 01 No. 40 | October 3, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

Bush Appoints Lander To NCAB

January 24, 2003

Congress Approves $4.19 Billion For NCI, $23.5 Billion For NIH, In FY2002 Appropriation.

January 4, 2002

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980